Nivolumab with gemcitabine plus cisplatin for biliary cancers: as easy as ABC?

被引：2
|
作者：
Franses, Joseph W. [1 ,2 ,3 ]
Hong, Theodore S. [1 ,2 ]
Zhu, Andrew X. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02114 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2019年 / 4卷 / 08期
关键词：
TRACT CANCER; PEMBROLIZUMAB;
D O I：
10.1016/S2468-1253(19)30148-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：575 / 577
页数：4
相关论文
共 50 条
  • [1] Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable NSCLC
    Zinner, R.
    Cowan, S.
    Solomides, C.
    Hooper, D. C.
    Harshyne, L.
    Lu-Yao, G.
    Yang, H.
    Phan, L.
    Poller, D.
    Leiby, B.
    Werner-Wasik, M.
    Lu, B.
    Johnson, J.
    Axelrod, R.
    Argiris, A.
    Evans, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1028 - S1029
  • [2] Cisplatin plus Gemcitabine for Biliary Tract Cancer
    Cariati, Andrea
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02): : 192 - 192
  • [3] Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
    Weigt, Jochen
    Malfertheiner, Peter
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 394 - 396
  • [4] Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study
    Feng, Kaichao
    Liu, Yang
    Zhao, Yongtian
    Yang, Qingming
    Dong, Liang
    Liu, Jiejie
    Li, Xiang
    Zhao, Zhikun
    Mei, Qian
    Han, Weidong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [5] Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers
    Lowery, Maeve A.
    Bradley, Mikaela
    Chou, Joanne F.
    Capanu, Marinela
    Gerst, Scott
    Harding, James J.
    El Dika, Imane
    Berger, Michael
    Zehir, Ahmet
    Ptashkin, Ryan
    Wong, Philip
    Rasalan-Ho, Teresa
    Yu, Kenneth H.
    Cercek, Andrea
    Morgono, Ezra
    Salehi, Erica
    Valentino, Emily
    Hollywood, Ellen
    O'Reilly, Eileen M.
    Abou-Alfa, Ghassan K.
    CLINICAL CANCER RESEARCH, 2019, 25 (03) : 937 - 945
  • [6] Nivolumab plus cisplatin/pemetrexed or cisplatin/gemcitabine as induction in resectable NSCLC.
    Evans, Nathaniel R.
    Cowan, Scott
    Solomides, Charalambos
    Hooper, D. Craig
    Harshyne, Larry
    Lu-Yao, Grace L.
    Yang, Hushan
    Phan, Linda
    Poller, Dawn
    Leiby, Benjamin
    Werner-Wasik, Maria
    Lu, Bo
    Johnson, Jennifer Maria
    Axelrod, Rita Susan
    Argiris, Athanassios
    Zinner, Ralph
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
    Valle, Juan
    Wasan, Harpreet
    Palmer, Daniel H.
    Cunningham, David
    Anthoney, Alan
    Maraveyas, Anthony
    Madhusudan, Srinivasan
    Iveson, Tim
    Hughes, Sharon
    Pereira, Stephen P.
    Roughton, Michael
    Bridgewater, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14): : 1273 - 1281
  • [8] Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma
    van der Heijden, M. S.
    Sonpavde, G.
    Powles, T.
    Necchi, A.
    Burotto, M.
    Schenker, M.
    Sade, J. P.
    Bamias, A.
    Beuzeboc, P.
    Bedke, J.
    Oldenburg, J.
    Chatta, G.
    Urun, Y.
    Ye, D.
    He, Z.
    Valderrama, B. P.
    Ku, J. H.
    Tomita, Y.
    Filian, J.
    Wang, L.
    Purcea, D.
    Patel, M. Y.
    Nasroulah, F.
    Galsky, M. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (19): : 1778 - 1789
  • [9] Gemcitabine alone or plus cisplatin for biliary tract cancer?
    Scheithauer, Werner
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (10) : 554 - 555
  • [10] Gemcitabine alone or plus cisplatin for biliary tract cancer?
    Werner Scheithauer
    Nature Reviews Clinical Oncology, 2010, 7 : 554 - 555
12345